Important context: This guide is educational. It does not say that kratom is safe, FDA-approved, or appropriate for treating any condition. FDA states that kratom is not lawfully marketed in the United States as a drug product, dietary supplement, or food additive in conventional food, and it warns consumers about serious risks. Laboratory testing is a quality-information tool, not medical advice or a safety guarantee.
The short answer
A laboratory report can provide useful evidence about a specific sample tested for specific substances by specific methods. It may help answer questions such as:
- Does the submitted sample contain chemical markers consistent with Mitragyna speciosa?
- What amounts of named alkaloids did the method measure?
- Were named heavy metals detected, and at what reported concentrations?
- Was the submitted analytical portion positive or negative for named microorganisms under the stated method?
- Did the measured results meet the specifications shown on the report?
But even a professional-looking report cannot prove everything a shopper may assume. It cannot, by itself, prove that the package in a customer’s hand came from the tested lot. It cannot prove that every unit in a large batch is identical. It cannot rule out substances that were not included in the panel. It cannot convert “not detected” into “absolutely absent.” It cannot prove a product will affect every person the same way. It cannot establish that a product is FDA-approved, medically effective, or lawful in every jurisdiction.
The most trustworthy way to use lab information is to read it as one part of a larger quality system: correct batch matching, representative sampling, appropriate methods, defined specifications, competent review, controlled packaging, traceability, and a process for responding when something does not match.
“Lab tested” is a claim that needs details
The phrase “lab tested” sounds reassuring, but it is incomplete. A meaningful testing claim should answer at least six questions:
- What product or material was sampled? Raw leaf, finished powder, filled capsules, extract, or another form?
- Which lot or batch was tested? The identifier on the report should match the identifier on the package.
- What was tested? Identity markers, named alkaloids, heavy metals, microorganisms, residual solvents, pesticides, or another panel?
- Which method was used? A report should identify the analytical method or a traceable method reference.
- What were the result and units? A number without units is not interpretable.
- What specification or decision rule was applied? A result is not automatically a “pass” unless there is a defined acceptance criterion and a valid comparison.
A page that says only “third-party tested” gives much less information than one that links the correct lot to an actual report showing analytes, methods, units, detection limits, results and specifications.
This distinction matters because “tested” does not necessarily mean “tested for everything,” “tested after final packaging,” “passed every relevant specification,” or “tested by an accredited laboratory for that exact method.” Customers should be able to see what the claim actually covers.
The five testing layers a buyer should understand
No single laboratory test answers every quality question. A useful program combines several layers, each designed for a different purpose.
1. Identity testing: is the material what the label says it is?
Identity testing asks whether a material is consistent with its declared botanical identity. Depending on the material and method, a laboratory may use microscopy, chemical fingerprints, chromatography, DNA-based techniques, or a combination of approaches.
Each technique has limits. Microscopy may be useful for recognizing characteristic plant structures in minimally processed material but can become less informative after very fine grinding or extraction. Chemical analysis may show characteristic compounds, but the presence of one marker is not always enough to establish complete botanical identity or purity. DNA methods may be valuable in some settings, while processing, extraction, degradation, mixtures, or reference-database limitations may complicate interpretation.
That is why a serious identity program begins with a question: Which method is scientifically appropriate for this material in this form? The answer may differ for leaf powder, a capsule filled with leaf powder, and a concentrated extract.
Identity is also different from variety naming. Labels such as Green Maeng Da, Red Bali, White Hulu, Green Ketapang, Red Vietnam, or White Malay are commercial catalog names. A chemical identity test may support the presence of Mitragyna speciosa, but it does not automatically authenticate every geographic or color implication in a marketing name. A responsible seller should describe those names as catalog families unless supplier documentation and a defensible verification program support more specific claims.
2. Alkaloid testing: what named compounds were measured?
Kratom contains multiple alkaloids. An alkaloid panel can measure specified compounds using an analytical method such as liquid chromatography with ultraviolet, diode-array, or mass-spectrometric detection. A report should state which alkaloids were included, because an entry for mitragynine does not mean every alkaloid was measured.
The most useful consumer-facing questions are:
- Is mitragynine reported?
- Is 7-hydroxymitragynine, commonly called 7‑OH, reported?
- Are the units percent by weight, milligrams per gram, milligrams per serving, or something else?
- Is the value an actual measured result, an approximate label claim, or a reporting threshold?
- Was the sample ordinary botanical leaf, an extract, or an enhanced product?
Units must be compared carefully. One percent by weight equals 10 milligrams per gram, but a result stated as a percentage cannot be compared directly with a milligram-per-package statement until the relevant product mass and basis are known. “Total alkaloids” also should not be treated as interchangeable with mitragynine, 7‑OH, or any single compound.
An alkaloid result is a chemical measurement. It is not a dosage recommendation, an effects prediction, or a guarantee of safety. People vary, product matrices vary, and laboratory measurements do not determine how an individual will respond.
Ordinary leaf versus enhanced 7‑OH
This distinction deserves its own line on every relevant report and product page.
Ordinary botanical leaf powder and capsules contain ground plant material. Extracts concentrate selected constituents relative to the starting material. Enhanced 7‑OH products may contain 7‑OH as an added ingredient or at levels not characteristic of ordinary leaf. FDA’s July 29, 2025 consumer update specifically distinguishes trace amounts naturally present in kratom from products with 7‑OH added or enhanced, and recommends that consumers avoid 7‑OH products.
A trustworthy product listing should never let customers infer that an enhanced tablet, gummy, shot, or drink mix is simply another “strain” of leaf. The product form, concentration basis, ingredients, and laboratory panel should make the distinction unmistakable.
For Kiody’s botanical powder and pure-leaf capsule catalog, the testing language should state the actual form and should not imply that those products are concentrated 7‑OH products. If a result is used to support that distinction, the report must match the finished lot and use an appropriate, sufficiently sensitive method.
3. Heavy-metal testing: which elements were measured and how much was found?
Botanical materials can pick up elements from soil, water, processing equipment, handling, or packaging. A heavy-metal panel commonly reports lead, arsenic, cadmium and mercury, but panel composition can vary. Some reports include additional elements such as nickel.
FDA has published results from testing 30 kratom products and reported significant lead and nickel concentrations in that sample set. That historical finding does not prove that every kratom product has the same contamination, and it does not describe any untested Kiody lot. It does show why lot-specific elemental testing and transparent results matter.
When reading a heavy-metal result, check:
- The exact element, not merely the phrase “heavy metals”
- Whether arsenic or mercury is reported as total content or a particular chemical species
- The result and unit, such as micrograms per gram or parts per million
- The method, commonly an elemental technique such as ICP-MS
- The reporting limit
- The specification and the basis used to set it
- Whether the specification is concentration-based, exposure-based, or tied to a stated daily amount
A concentration alone does not describe exposure. Exposure depends on concentration and the amount consumed. Conversely, a small serving statement does not erase a contamination result. A responsible comparison keeps concentration, product quantity, use assumptions, and applicable requirements separate and explicit.
FDA’s Elemental Analysis Manual explains analytical practices for toxic and nutritional elements and includes methods using technologies such as inductively coupled plasma-mass spectrometry. It also emphasizes terminology, detection and quantitation, measurement uncertainty, sampling uncertainty, reference materials and method performance. A seller does not need to reproduce a technical manual for shoppers, but its quality team should understand that a credible number rests on more than an instrument printout.
4. Microbiology testing: what organisms or indicators were examined?
Microbiology panels often include both pathogens and general indicators. Examples may include:
- Salmonella species
- Shiga toxin-producing or specified E. coli
- Total aerobic microbial count
- Yeast and mold
- Coliforms or Enterobacteriaceae
These entries do not all mean the same thing. A total-count result estimates organisms under the method’s defined conditions. A pathogen test asks a more specific presence/absence or enumeration question. A low total aerobic count is not a substitute for a valid Salmonella result. Likewise, “microbial tested” does not show that every relevant pathogen was included.
FDA’s current Bacteriological Analytical Manual identifies preferred FDA procedures for microbiological analysis. Its January 2026 Salmonella chapter includes screening and cultural confirmation workflows. FDA guidance also warns that contamination may not be homogeneous: one sample can test negative even when contamination is present elsewhere in a lot. FDA recommends proper sampling and handling, use of the BAM cultural method or a similarly validated method, and treating a confirmed positive as valid even if later samples test negative absent a clear reason the first result was inaccurate.
This is a crucial limitation. A negative pathogen result is valuable evidence about the submitted analytical portion under the method used. It is not a promise that no organism exists anywhere in every package. Sampling design, lot controls, sanitation, supplier qualification, handling, storage and investigation procedures remain essential.
5. Product-form-specific testing: does the panel fit the process?
Testing should reflect how a product was made.
For plain leaf powder, identity, alkaloids, heavy metals and microbiology may form the central panel. For pure-leaf capsules, the program should also control capsule-shell identity, fill-weight consistency, ingredient reconciliation and finished-product traceability. A raw-material COA alone may not answer what happened during encapsulation and final packaging.
For extracts, additional questions can include extraction solvents, concentration, carriers, standardization and whether the finished form matches the labeled composition. Residual-solvent testing may be relevant when solvents are used. It should not be advertised as a universal feature if it was not performed or was not relevant to the process.
For gummies, shots, drink mixes or multi-ingredient products, microbiology and chemical questions may differ because the matrix, water activity, ingredients and manufacturing process differ. A method validated for one matrix may not be suitable for another without evidence.
The principle is simple: the panel should follow the product and its risks, not a marketing template.
Why the sample matters as much as the instrument
A sophisticated instrument cannot fix an unrepresentative sample.
Imagine a large batch with contamination in one small portion. If the laboratory receives only material from a clean section, the test may not detect the problem. FDA’s regulations for dietary-supplement manufacturing define a representative sample as an adequate number of units drawn using rational criteria, such as random sampling, intended to accurately portray the material sampled. FDA does not recognize kratom as a lawful dietary supplement; A responsible seller should cite these rules only as a quality-system benchmark, not as a legal classification for kratom.
Useful questions for a company’s internal quality file include:
- Who collected the sample?
- From how many containers or locations was it drawn?
- Was the sampling method written and followed?
- Was the sample sealed, labeled and protected from mix-ups?
- Did the laboratory receive enough material?
- Was the tested material raw input, in-process material, bulk finished product, or retail-ready units?
- Can the report be traced back to the packaged lot customers receive?
Customer-facing pages do not need to publish every internal procedure, but a company should be able to explain its sampling level accurately. “Every batch tested” should mean the company can identify what constitutes a batch, what sample represented it, which panels were run, and what happened when a specification was not met.
Understanding results, limits and units
Laboratory abbreviations are easy to misread. The report should define its terms, but these general explanations help.
ND: not detected
“ND” usually means the method did not detect the analyte at or above a stated detection or reporting limit. It does not mean the analyte is mathematically zero. A report is more informative when it shows the relevant limit beside the ND result.
LOD: limit of detection
The limit of detection is associated with the lowest amount the method can distinguish from background under defined conditions. Exact definitions and calculations can vary by method and laboratory.
LOQ: limit of quantitation
The limit of quantitation is associated with the lowest level that can be quantitatively reported with acceptable performance under defined conditions. A signal may be detected below the LOQ without supporting a reliable exact concentration.
RL or reporting limit
A reporting limit is the level at or above which the laboratory reports a quantitative result according to its procedure. It may reflect method capability, dilution, matrix effects, client requirements, or policy. Ask the laboratory or seller how the term is defined on that report.
CFU/g and presence/absence
CFU/g means colony-forming units per gram under the method’s culture conditions. Presence/absence results apply to the tested analytical portion, often stated with a sample mass. “Absent in 25 g” is not the same reporting format as a numerical count per gram.
Percent, ppm, ppb, mg/g and µg/g
Units determine meaning. In many mass-based contexts, 1% equals 10 mg/g; 1 ppm equals 1 µg/g; and 1 ppb equals 1 ng/g. Those conversions assume compatible mass-per-mass bases. Moisture correction, extract basis, serving basis and laboratory conventions can affect comparisons. If units or basis are unclear, do not guess.
What ISO/IEC 17025 accreditation adds—and what it does not
ISO/IEC 17025 is an international standard for the competence of testing and calibration laboratories. Accreditation by a recognized body can provide evidence that a laboratory has been assessed for defined capabilities, quality processes and technical competence.
The key word is scope. A laboratory may be accredited, while a particular analyte, matrix, or method falls outside its accredited scope. A careful reviewer should check:
- The laboratory’s exact legal name and location
- The accreditation body
- The certificate’s effective and expiration dates
- The laboratory’s scope of accreditation
- Whether the relevant chemistry or microbiology method appears within that scope
- Whether the report marks results performed outside the accredited scope
The International Laboratory Accreditation Cooperation maintains information about signatory accreditation bodies and explains that its Mutual Recognition Arrangement is based on peer evaluation. This helps verify the accreditation chain. Still, accreditation does not prove that the seller supplied a representative sample, that the report matches the package, that no transcription error occurred, or that every possible analyte was tested.
Accreditation strengthens evidence. It does not replace traceability or judgment.
A “pass” result needs a real specification
Customers often look for green checkmarks or the word “PASS.” The harder question is: passed against what?
A specification should identify an acceptance criterion, its units, and its basis. For example, a microbiological criterion might be presence/absence in a defined analytical portion. A heavy-metal specification might be expressed as a maximum concentration or tied to a documented exposure calculation. An alkaloid specification might set an identity or composition range.
The laboratory can report measurements, but responsibility for choosing valid product specifications does not disappear. A seller should not invent a permissive limit after seeing a result, borrow a limit that applies to a different product category without explanation, or label an analyte “pass” when no criterion is shown.
FDA’s dietary-supplement CGMP rules provide a useful quality-system model: establish specifications for identity, purity, strength, composition and contaminant limits; use appropriate tests or examinations; document why the selected checks verify the finished batch; and qualify a supplier before relying on its certificate. Again, FDA states that kratom is not lawfully marketed as a dietary supplement, so A responsible seller should present Part 111 as a quality-literacy reference rather than a claim of regulatory acceptance.
Nine red flags on a kratom laboratory report
Pause and ask questions if you see any of these:
- No lot or batch identifier. There is no reliable way to match the report to the package.
- A mismatched identifier. Similar names are not enough; the package and report need a traceable connection.
- No sample description or unclear product form. A raw-leaf report should not silently stand in for a finished extract or capsule lot.
- No laboratory identity or contact information. The report cannot be independently verified.
- Results without units. “0.8” has no useful meaning until the unit and basis are known.
- A “pass” with no specification. The acceptance rule is hidden or missing.
- ND with no detection or reporting limit. The reader cannot tell how sensitive the reported result was.
- A cropped screenshot or altered graphic instead of the full report. Important pages, qualifiers or signatures may be missing.
- A generic report reused across unrelated products or dates. One sample cannot establish the status of every later batch.
Other concerns include expired accreditation presented as current, a product name that does not match the tested matrix, inconsistent dates, implausible unit conversions, copied numbers across many lots, missing pages, or marketing claims that go beyond the report.
A two-minute customer checklist
Before relying on a COA or laboratory summary, check the following:
- Match: Does the package lot match the report?
- Form: Does the report identify powder, capsules, extract or another finished form?
- Date: Is the report reasonably connected to the product lot rather than merely “recent”?
- Panel: Are the exact analytes listed?
- Method: Is a method or method reference shown?
- Units: Can you tell whether results are percent, ppm, mg/g, CFU/g or presence/absence?
- Limits: Are ND, LOD, LOQ or reporting limits explained?
- Criteria: If the report says “pass,” is the specification visible?
- Laboratory: Is the laboratory identifiable, and can its accreditation scope be checked?
- Completeness: Is the full report available rather than a cropped marketing image?
- Product distinction: Is ordinary leaf clearly separated from extracts and enhanced 7‑OH products?
- Support: Is there a way to ask about a mismatch or report a problem?
If the answers are unclear, the responsible next step is to request clarification—not to fill the gaps with assumptions.
What laboratory testing cannot establish
Even a strong testing program has boundaries. A laboratory report cannot, on its own:
- Guarantee that a product is harmless
- Predict an individual’s response
- Establish a medically effective amount
- Approve claims to diagnose, treat, cure, mitigate or prevent disease
- Prove compliance with every federal, state and local requirement
- Establish legality in a customer’s destination
- Prove the absence of every contaminant not included in the panel
- Prove that every unit in a lot is identical
- Replace manufacturing controls, sanitation, supplier qualification or complaint review
- Authenticate marketing claims about geography, harvest season, color effects or “premium” status without supporting evidence
- Make enhanced 7‑OH equivalent to ordinary botanical leaf
The honest conclusion is not that testing is useless. It is that testing is strongest when its scope is precise.
Frequently asked questions
Does “third-party tested” mean a product is FDA-approved?
No. An independent laboratory result is not FDA approval. FDA states that there are no FDA-approved prescription or over-the-counter drug products containing kratom or its known alkaloids legally on the U.S. market. FDA also states that kratom is not lawfully marketed as a dietary supplement or added to conventional food.
Does a COA prove the product in my package was tested?
Only if the traceability is credible. The lot or batch code on the package should match the report, the sample should represent that lot, and the product form should align. A generic or mismatched COA does not establish that connection.
Does “ND” mean zero?
No. It generally means the analyte was not detected at or above a stated detection or reporting limit under that method. Look for the relevant limit and units.
Is one test enough for a batch?
That depends on the risk, product, batch design, sampling plan and specification. One laboratory portion may not represent heterogeneous contamination. A company should use a rational sampling plan and document why the selected tests support its quality decision.
Are lead, arsenic, cadmium and mercury the only elements that matter?
They are common panel entries, but they are not the only elements a laboratory can measure. FDA’s published kratom testing also reported nickel. The appropriate panel should be based on product and supplier risks rather than a generic label.
Does a low total microbial count prove there is no Salmonella?
No. General microbial counts and pathogen-specific methods answer different questions. A product should not be described as free of Salmonella based only on an unrelated total-count result.
Does an alkaloid percentage show how a product will feel?
No. It is a chemical measurement for the tested sample. It does not predict an individual effect, establish a dosage, or prove safety.
Can a mitragynine result verify a color or variety name?
Not by itself. Commercial names such as Green Maeng Da or Red Bali are catalog labels. A mitragynine measurement does not automatically verify the marketing implications of color, geography or harvest tradition.
Are botanical leaf and enhanced 7‑OH the same product type?
No. Ordinary leaf contains naturally occurring alkaloids in the plant matrix. Enhanced 7‑OH products contain added or elevated 7‑OH and should be clearly distinguished from leaf powder and pure-leaf capsules. FDA recommends consumers avoid products containing added or enhanced 7‑OH.
Should I trust a laboratory just because its logo appears on a report?
Verify the laboratory independently. Check its name, contact information, accreditation certificate and scope. A logo alone does not confirm authenticity or that the relevant method was within scope.
Why might two laboratories report different numbers?
Differences can arise from sampling, sample preparation, product heterogeneity, method design, calibration, matrix effects, moisture basis, units, detection limits and measurement uncertainty. A quality review should investigate meaningful differences rather than automatically selecting the preferred number.
Should Kiody publish every internal quality record?
Not necessarily. Customer transparency should include the information needed to match and interpret a lot-level report. Internal records may contain supplier-confidential or operational information. The public summary must still be accurate, complete enough to understand, and supported by controlled records.
The bottom line
The best laboratory claim is not the biggest claim. It is the most specific one.
Customers deserve to know what was sampled, which lot it represents, which analytes were tested, what methods and units were used, what the results mean, and where the limits of the evidence begin. A responsible seller can build trust by connecting every botanical powder and pure-leaf capsule page to the correct lot information, using complete reports, separating ordinary leaf from extracts and enhanced 7‑OH, and avoiding claims the data cannot support.
A good laboratory report does not end the quality conversation. It makes an honest conversation possible.
Primary and authoritative sources
- U.S. Food and Drug Administration, FDA and Kratom, updated December 2, 2025. FDA’s current federal position, warnings, and contamination history.
- U.S. Food and Drug Administration, Laboratory Analysis of Kratom Products for Heavy Metals. FDA reports results from 30 sampled kratom products, including lead and nickel measurements.
- U.S. Food and Drug Administration, Elemental Analysis Manual for Food and Related Products, current page reviewed August 28, 2026. Methods, terminology, sampling uncertainty, measurement uncertainty and method-performance resources.
- U.S. Food and Drug Administration, Bacteriological Analytical Manual, updated August 6, 2026. FDA’s preferred microbiological laboratory procedures.
- U.S. Food and Drug Administration, BAM Chapter 5: Salmonella, January 2026 edition.
- U.S. Food and Drug Administration, Guidance for Industry: Testing for Salmonella Species in Human Foods and Direct-Human-Contact Animal Foods, March 2012. Sampling, validated methods, result interpretation and heterogeneous contamination.
- Electronic Code of Federal Regulations, 21 CFR Part 111, current through August 28, 2026. Used only as a quality-system benchmark for definitions, specifications, representative sampling, appropriate testing and supplier COA qualification; not as a claim that FDA accepts kratom as a dietary supplement.
- International Laboratory Accreditation Cooperation, ILAC MRA and Signatories. Accreditation-body peer evaluation and signatory verification.
- U.S. Food and Drug Administration, Products Containing 7‑OH Can Cause Serious Harm, July 29, 2025. Distinction between trace naturally occurring 7‑OH and added or enhanced 7‑OH products.
- Sharma A, et al., Simultaneous quantification of ten key kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography–tandem mass spectrometry, 2019. Peer-reviewed analytical-method validation reference.